An economic analysis of erlotinib, docetaxel, pemetrexed...

An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer

A. Araújo, B. Parente, R. Sotto-Mayor, E. Teixeira, T. Almodôvar, F. Barata, H. Queiroga, C. Pereira, H. Pereira, F. Negreiro, C. Silva
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Year:
2008
DOI:
10.1016/s2173-5115(08)70309-9
File:
PDF, 288 KB
2008
Conversion to is in progress
Conversion to is failed